Client of a consultant lobbyist
Becton Dickinson Canada Inc
- Meetings this Parliament
- 3
- With MPs
- 2
- Since Nov 2021
- 5
- Active registrations
- 0
Most recent reported meeting: Apr 23, 2026.
Lobbying by Becton Dickinson Canada Inc: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Becton Dickinson Canada Inc has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.
Reported meetings
Spreadsheet-
Reported by Danielle Flieler · Consultant
- Justine Frame · Policy Advisor, Health Canada (HC)
Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health. Read more
Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes.
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
-
Reported by Danielle Flieler · Consultant
- Maggie Chi · Parliamentary Secretary, Health Canada (HC)
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
- Bruce Randall · Director General of Medical Devices, Health Canada (HC)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
and 1 moreShow fewer
- Jibril Hussein · Intern, Health Canada (HC)
Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health. Read more
Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies
Federal science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry
Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes.
Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
-
Reported by Danielle Flieler · Consultant
- Maggie Chi · Parliamentary Secretary, Health Canada (HC)
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
- Jibril Hussein · Intern, Innovation, Science and Economic Development Canada (ISED)
- Justine Frame · Special Assistant, Policy, Health Canada (HC)
and 2 moreShow fewer
- Bruce Randall · Director General of Medial Devices, Health Canada (HC)
- Daniel MacDonald · Director General Office of Pharmaceutical Management, Health Canada (HC)
Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes. Read more
Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health.
Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector
Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes.
-
Reported by Danielle Flieler · Consultant
- Stephen Ellis · Member of Parliament, House of Commons
- Robert Kitchen · Member of Parlilament, House of Commons
Health
-
Reported by Danielle Flieler · Consultant
- Ophelia John · Senior Policy Advisor, Health Canada (HC)
- Chelsea Madryga · Policy Advisor, Health Canada (HC)
Health
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.